These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12594286)

  • 1. Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.
    Precopio ML; Sullivan JL; Willard C; Somasundaran M; Luzuriaga K
    J Immunol; 2003 Mar; 170(5):2590-8. PubMed ID: 12594286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
    Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
    J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
    Piriou ER; van Dort K; Weel JF; Bemelman FJ; Gamadia LE; van Oers MH; van Baarle D
    Clin Immunol; 2006 Apr; 119(1):16-20. PubMed ID: 16386961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis.
    Fischer F; Mücke J; Werny L; Gerrer K; Mihatsch L; Zehetmaier S; Riedel I; Geisperger J; Bodenhausen M; Schulte-Hillen L; Hoffmann D; Protzer U; Mautner J; Behrends U; Bauer T; Körber N
    Virol J; 2024 Jun; 21(1):139. PubMed ID: 38877590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype.
    Maini MK; Gudgeon N; Wedderburn LR; Rickinson AB; Beverley PC
    J Immunol; 2000 Nov; 165(10):5729-37. PubMed ID: 11067931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis.
    Scherrenburg J; Piriou ER; Nanlohy NM; van Baarle D
    Clin Exp Immunol; 2008 Aug; 153(2):231-9. PubMed ID: 18549439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.
    Long HM; Leese AM; Chagoury OL; Connerty SR; Quarcoopome J; Quinn LL; Shannon-Lowe C; Rickinson AB
    J Immunol; 2011 Jul; 187(1):92-101. PubMed ID: 21622860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD; Patel J; Schwab H; Martinez J
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.
    Catalina MD; Sullivan JL; Bak KR; Luzuriaga K
    J Immunol; 2001 Oct; 167(8):4450-7. PubMed ID: 11591771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
    White CA; Cross SM; Kurilla MG; Kerr BM; Schmidt C; Misko IS; Khanna R; Moss DJ
    Virology; 1996 May; 219(2):489-92. PubMed ID: 8638417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.
    Long HM; Chagoury OL; Leese AM; Ryan GB; James E; Morton LT; Abbott RJ; Sabbah S; Kwok W; Rickinson AB
    J Exp Med; 2013 May; 210(5):933-49. PubMed ID: 23569328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.
    Catalina MD; Sullivan JL; Brody RM; Luzuriaga K
    J Immunol; 2002 Apr; 168(8):4184-91. PubMed ID: 11937579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.
    Kang I; Quan T; Nolasco H; Park SH; Hong MS; Crouch J; Pamer EG; Howe JG; Craft J
    J Immunol; 2004 Jan; 172(2):1287-94. PubMed ID: 14707107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins.
    Ning RJ; Xu XQ; Chan KH; Chiang AK
    Immunology; 2011 Oct; 134(2):161-71. PubMed ID: 21896011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of Epstein-Barr virus load and virus-specific CD8+ T cells in acute infectious mononucleosis.
    Hoshino Y; Nishikawa K; Ito Y; Kuzushima K; Kimura H
    J Clin Virol; 2011 Mar; 50(3):244-6. PubMed ID: 21185773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection.
    Woodberry T; Suscovich TJ; Henry LM; Davis JK; Frahm N; Walker BD; Scadden DT; Wang F; Brander C
    J Infect Dis; 2005 Nov; 192(9):1513-24. PubMed ID: 16206065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.